Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
Ethicon* joins world-renowned experts in bariatric surgery to share the latest breakthroughs in science and innovation that are advancing surgery in the fight against obesity and metabolic diseases during ObesityWeek 2016, the combined annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS). Ethicon will highlight the growing body of research and evidence on the benefits of bariatric surgery, a new sleeve gastrectomy training module on the Touch Surgery app, and its comprehensive portfolio of bariatric surgery products aimed to improve patient outcomes.
“Ethicon’s mission is to lead the way in resolving the burden of obesity for both patients and healthcare systems by expanding access to care and demonstrating the critical value of treatment through research and evidence, while also enabling new technologies,” said Dr. Elliott Fegelman, Therapeutic Area Expert, Metabolics, Johnson & Johnson Innovation.
To view the multimedia release go to:
http://www.multivu.com/players/English/7965651-ethicon-bariatric-surgery-access-obesity-week-2016/
Match, the world's largest relationship company, today released findings from its eighth annual Singles in America study – the nation’s largest, most comprehensive annual survey of 5,000+ single people living in the U.S. The 2017 survey captures surprising data and trends on shifting gender norms, the evolving rules of casual dating, the complications presented by technology and social media, as well as attitudes about love, sex, and relationships across generations.
“Singles are fundamentally redefining courtship in healthy and creative ways,” says Dr. Helen Fisher, biological anthropologist and Chief Scientific Advisor to Match. “Some hang out for months before they kiss; some hop into bed immediately; and many begin with the traditional first date. Courtship is expanding--and all these tactics are proving successful for launching love. Moreover, the first date is taking on important new significance: where it used to be just a casual look-see, now the first date often signals the official beginning of a romance. And singles want to define every step toward love--with a host of new rules on social media. Most exciting to me, 72% of singles would date ‘across the aisle.’ For most singles, romance is more important than politics. I’m not surprised. The human brain is built to love.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8264851-match-singles-in-america-study/
